Safety Profile Following Pentabio Vaccination in Indonesian Infants

Immunogenicity and Safety of DTP/HB/Hib (Bio Farma)Compared to DTP/HB Given Simultaneously With Hib(Registered)Vaccine

NCT01986322 ·Status: COMPLETED ·Phase: PHASE2

Evaluation on Immunogenicity and Safety Profile of Trivalent OPV (tOPV Bio Farma)

NCT02093273 ·Status: COMPLETED ·Phase: PHASE2

Retrospective Survey of Safety of Fourth Dose Pentacel® in Children

NCT00772369 ·Status: COMPLETED

Phase I/II, Open Label, Randomized, Safety and Immunogenicity Following DTwP-Hepatitis B-Hib-IPV Vaccine (Bio Farma) in Indonesian Infants

NCT06690515 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2

A Phase IV Study to Assess the Safety of EupentaTM Inj

NCT04056728 ·Status: UNKNOWN ·Phase: PHASE4

The Safety and Immunogenicity of DTP/Hepatitis B 10ug Hib Vaccine (Bio Farma)

NCT01977196 ·Status: COMPLETED ·Phase: PHASE1

Pentavalent DTaP-Hep B-IPV

NCT00133445 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate the Immunogenicity and Safety of LBVD(Hexavalent Vaccine), Given to Healthy Infants at Primary Series

NCT05457946 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

Safety of Hib Vaccine (Bio Farma)

NCT01977170 ·Status: COMPLETED ·Phase: PHASE1

Rates of Pertussis Disease Among Persons Receiving Pentacel® or Other Pertussis Vaccines

NCT01129362 ·Status: COMPLETED

Post Marketing Surveillance of Synflorix Vaccine Safety Among Infants in Korea

NCT01248988 ·Status: COMPLETED

Pneumococcal Vaccine Booster Study in Healthy Children 11-18 Months Old Previously Primed With the Same Vaccines

NCT00463437 ·Status: COMPLETED ·Phase: PHASE3

Immunogenicity and Safety of Pentaxim™ in an Indian Population

NCT00259337 ·Status: COMPLETED ·Phase: PHASE3

Evaluate Safety of ComBe Five (Liquid) in Healthy Vietnamese Children Aged From 8 - 10 Weeks as a 3-dose Series, Interval for Each Dose is 4 Weeks

NCT02904213 ·Status: COMPLETED ·Phase: NA

Immunogenicity Study of Antibody Persistence and Booster Effect of PENTAXIM™ at 18 Months in Healthy Argentinean Infants

NCT00303316 ·Status: COMPLETED ·Phase: PHASE3

Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants

NCT02096263 ·Status: COMPLETED ·Phase: PHASE3

Safety, Long Term Immunogenicity and Lot Consistency Study of Liquid Pentavalent Combination Vaccine

NCT00877357 ·Status: UNKNOWN ·Phase: PHASE4

Safety Study of GSK Biologicals' DTPa-IPV/Hib (Infanrix™-IPV/Hib)

NCT00964028 ·Status: COMPLETED ·Phase: PHASE3

Safety and Immunogenicity Study of a Liquid Pentavalent Combination Vaccine

NCT00617812 ·Status: COMPLETED ·Phase: PHASE4

Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® PEDIATRICO in Argentinean Infants

NCT00831311 ·Status: COMPLETED ·Phase: PHASE2

Immunogenicity and Safety of Pentaxim as 3 Doses Primary Vaccination Followed by a Booster Dose at 18 Months

NCT00453570 ·Status: COMPLETED ·Phase: PHASE3

Assess Immunogenicity, Reactogenicity, Safety of a Booster of GSK Biologicals DTPw-HBV/Hib Kft Compared to DTPw-HBV/Hib

NCT00332566 ·Status: COMPLETED ·Phase: PHASE3

A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent Diphtheria-tetanus-whole Cell Pertussis-hepatitis B-poliovirus-Haemophilus Influenzae Type b Conjugate (DTwP-HepB-IPV-Hib) Vaccine, in Healthy Infants as Primary Series

NCT06947499 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

Post-marketing Surveillance to Assess the Safety of Boostrix Vaccine Given According to Prescribing Information in Korea

NCT01929291 ·Status: COMPLETED

Post-marketing Safety Study of GSK Biological's Pediarix™ Vaccine

NCT00146835 ·Status: COMPLETED